This Research Topic will coincide with the 50th anniversary of the first heart transplant performed in December of 1967 in Cape Town, South Africa. Cardiovascular researchers will meet in South Africa in December 2017 to celebrate this event, presenting an opportune time to reflect on the achievements of applied cardiovascular research and highlight forthcoming technology developments that will shape the future of cardiovascular medicine. The clinical breakthrough in 1967 offered hope to many patients suffering with cardiac complications, and these life-saving surgeries continue to have a tremendous impact. Tissue shortages, surgical risks, and complications due to improper host-transplant tissue interactions, however, limit the utility of heart transplants to the most severe cases of cardiac morbidity. Recent advances have yielded mechanistic insight into the factors that control cardiovascular tissue maintenance and remodeling. The field of regenerative medicine seeks to control these factors to promote in situ tissue regeneration or engineered tissue replacement. These exciting new technologies could lead to a renaissance in the treatment of many cardiovascular diseases, just as the realization of heart transplantation 50 years ago. In this Research Topic, researchers and clinicians from regenerative medicine and applied cardiovascular biology are welcome to provide literature reviews and original manuscripts to demonstrate the trajectory of cardiovascular medicine. The contributions will vertically integrate advances by clinicians, engineers, and basic scientists, all researching similar topics from different angles and with complementary perspectives. This Research Topic will include both basic and clinical studies pertaining to new methodologies and discoveries within regenerative medicine. Taken together, these contributions will demonstrate the process of applied cardiovascular research from basic science discoveries to implementation in clinical practice.
This Research Topic will coincide with the 50th anniversary of the first heart transplant performed in December of 1967 in Cape Town, South Africa. Cardiovascular researchers will meet in South Africa in December 2017 to celebrate this event, presenting an opportune time to reflect on the achievements of applied cardiovascular research and highlight forthcoming technology developments that will shape the future of cardiovascular medicine. The clinical breakthrough in 1967 offered hope to many patients suffering with cardiac complications, and these life-saving surgeries continue to have a tremendous impact. Tissue shortages, surgical risks, and complications due to improper host-transplant tissue interactions, however, limit the utility of heart transplants to the most severe cases of cardiac morbidity. Recent advances have yielded mechanistic insight into the factors that control cardiovascular tissue maintenance and remodeling. The field of regenerative medicine seeks to control these factors to promote in situ tissue regeneration or engineered tissue replacement. These exciting new technologies could lead to a renaissance in the treatment of many cardiovascular diseases, just as the realization of heart transplantation 50 years ago. In this Research Topic, researchers and clinicians from regenerative medicine and applied cardiovascular biology are welcome to provide literature reviews and original manuscripts to demonstrate the trajectory of cardiovascular medicine. The contributions will vertically integrate advances by clinicians, engineers, and basic scientists, all researching similar topics from different angles and with complementary perspectives. This Research Topic will include both basic and clinical studies pertaining to new methodologies and discoveries within regenerative medicine. Taken together, these contributions will demonstrate the process of applied cardiovascular research from basic science discoveries to implementation in clinical practice.